LifeMD, Inc. (LFMD), a prominent player in the healthcare sector, presents an intriguing investment opportunity with a potential upside of 24.96%. As a direct-to-patient telehealth provider, LifeMD connects consumers with..
Enhabit, Inc. (EHAB), a prominent player in the healthcare sector, offers a comprehensive range of home health and hospice services across the United States. With a market capitalization of $348.89..
Bioventus Inc. (NASDAQ: BVS), a prominent player in the medical devices sector, is drawing attention from investors with its robust product line aimed at addressing pain relief and musculoskeletal therapies...
Keros Therapeutics, Inc. (NASDAQ: KROS) presents an intriguing opportunity in the biotechnology sector, with analysts projecting a substantial 66.9% potential upside. This clinical-stage biopharmaceutical company, headquartered in Lexington, Massachusetts, focuses..
Beta Bionics, Inc. (NASDAQ: BBNX), a forward-thinking company in the healthcare sector, is making waves in the medical device industry with its innovative solutions for diabetes management. With a market..
For investors seeking opportunities in the dynamic biotechnology sector, Upstream Bio, Inc. (NASDAQ: UPB) presents a compelling case with a standout potential upside of 272.03%. As a clinical-stage biotechnology company,..
Talkspace, Inc. (NASDAQ: TALK), a trailblazer in the virtual behavioral healthcare sector, is garnering significant attention from investors with its compelling growth narrative and substantial potential upside. With a current..
Owens & Minor, Inc. (NYSE: OMI) stands as a pivotal player in the healthcare distribution sector, offering a comprehensive array of products and services through its two key segments: Products..
Investors looking for opportunities in the healthcare sector might find Auna SA (AUNA) an intriguing prospect. This Luxembourg-based company operates hospitals and clinics across Mexico, Peru, and Colombia, offering a..
Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a notable player in the healthcare sector, particularly within the drug manufacturing industry for specialty and generic pharmaceuticals. Based in Teaneck, New..
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a prominent player in the healthcare sector, is making waves in the biotechnology industry with its innovative therapies aimed at chronic endocrine and neurological..
Investors with an eye on the biotechnology sector should take note of Stoke Therapeutics, Inc. (NASDAQ: STOK), a promising player in the field of genetic disease treatment. With a market..
Akso Health Group (NASDAQ: AHG) has been making waves in the healthcare sector, particularly in the niche of medical distribution in China. With a market cap of $697.24 million, Akso..
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is making waves in the biotechnology sector with its focus on developing treatments for rare diseases. Headquartered in Celebration, Florida, this commercial-stage company has been..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is captivating the attention of investors with its ambitious gene therapy pipeline and a compelling potential upside of 171.03%. As a late-stage biotechnology company, Rocket..
Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the healthcare sector, stands out in the medical devices industry with its innovative ultrasound imaging solutions. Headquartered in Burlington, Massachusetts, the..
Fulgent Genetics, Inc. (NASDAQ: FLGT), a key player in the Healthcare sector, specifically within the Diagnostics & Research industry, presents an intriguing investment opportunity for those interested in the evolving..
Bicycle Therapeutics plc (NASDAQ: BCYC) is capturing investor attention with its innovative approach in the biotechnology sector. Based in Cambridge, United Kingdom, this clinical-stage pharmaceutical company is making strides in..
ArriVent BioPharma, Inc. (AVBP) is capturing attention in the biotechnology sector with its promising clinical-stage projects focused on addressing unmet medical needs in cancer treatment. As investors sift through potential..
Zenas BioPharma, Inc. (NASDAQ: ZBIO) is steadily capturing investor attention within the biotechnology sector, boasting a compelling potential upside of nearly 97%. Headquartered in Waltham, Massachusetts, this clinical-stage biopharmaceutical company..
